Synthesis of amphiphilic resveratrol lipoconjugates and evaluation of their anticancer activity towards neuroblastoma SH-SY5Y cell line

European Journal of Medicinal Chemistry

Volumn 96, Issue , 2015, Pages 467-481

  Chillemi, Rosa ^a   Cardullo, Nunzio ^a   Greco, Valentina ^b   Malfa, Giuseppe ^a   Tomasello, Barbara ^a   Sciuto, Sebastiano ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b CNR   (Italy)

Author keywords

Amphiphilic resveratrol lipoconjugates; Antitumour activity; Human fibroblasts; Neuroblastoma SH SY5Y cells; Resveratrol

Indexed keywords

AMPHOPHILE; MEMBRANE LIPID; PHOSPHORAMIDOUS ACID; RESVERATROL; ANTINEOPLASTIC AGENT; LIPID; STILBENE DERIVATIVE; SURFACTANT;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONJUGATE; CONTROLLED STUDY; DRUG SYNTHESIS; FIBROBLAST; HUMAN; HUMAN CELL; IC50; LIPID BILAYER; NEUROBLASTOMA CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; NEUROBLASTOMA; PATHOLOGY; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LIPIDS; MOLECULAR STRUCTURE; NEUROBLASTOMA; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE-ACTIVE AGENTS;

EID: 84928677724     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2015.04.038     Document Type: Article

References (37)

1. P. Jeandet, R. Bessis, M. Sbaghi, P. Meunier, P. Trollat, Resveratrol content of wines of different ages: relationship with fungal disease pressure in the vineyard, Am. J. Enol. Vitic. 46 (1995) 1-4.
2. M.J. Takaoka, Of the phenolic substances of white hellebore (Veratrum grandiflorum Loes. fil.), J. Fac. Sci. Hokkaido Imp. Univ. 3 (1940) 1-16.
3. S. Nonomura, H. Kanagawa, A. Makimoto, Chemical constituents of polygonaceous plants. I. Studies on the components of Ko-jo-kon (Polygonum cuspidatum Sieb. et Zucc.), Yakugaku Zasshi 83 (1963) 988-990.
4. J. Burns, T. Yokota, H. Ashihara, M.E.J. Lean, A. Crozier, Plant foods and herbal sources of resveratrol, J. Agric. Food Chem. 50 (2002) 3337-3340.
5. S.K. Goswami, D.K. Das, Resveratrol and chemoprevention, Cancer Lett. 284 (2009) 1-6.
6. B.B. Aggarwal, S. Shishodia, Resveratrol in health and disease, in: Oxidative Stress and Disease, vol. 20, Taylor & Francis, London, 2006, pp. 1-712.
7. S. Renaud, M. de Lorgeril, Wine, alcohol, platelets, and the French paradox for coronary heart disease, Lancet 339 (1992) 1523-1526.
8. K. Szkudelska, T. Szkudelski, Resveratrol, obesity and diabetes, Eur. J. Pharmacol. 635 (2010) 1-8.
9. S.-M. Lee, H. Yang, D.M. Tartar, B. Gao, X. Luo, S.Q. Ye, H. Zaghouani, D. Fang, Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes, Diabetologia 54 (2011) 1136-1146.
10. T.S. Anekonda, Resveratrolea boon for treating Alzheimer's disease? Brain Res. Rev. 52 (2006) 316-326.
11. D. Albani, L. Polito, A. Signorini, G. Forloni, Neuroprotective properties of resveratrol in different neurodegenerative disorders, BioFactors 36 (2010) 370-376.
12. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, H.H. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon, J.M. Pezzuto, Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, Science 275 (1997) 218-220.
13. J.A. Baur, D.A. Sinclair, Therapeutic potential of resveratrol: the in vivo evidence, Nat. Rev. Drug Discov. 5 (2006) 493-506.
14. D. Aleo, V. Cardile, R. Chillemi, G. Granata, S. Sciuto, Chemoenzymatic synthesis and some biological properties of O-phosphoryl derivatives of (E)- resveratrol, Nat. Product. Commun. 3 (2008) 1693-1700.
15. K.R. Patel, E. Scott, V.A. Brown, A.J. Gescher, W.P. Steward, K. Brown, Clinical trials of resveratrol, Ann. N. Y. Acad. Sci. 1215 (2011) 161-169.
16. A.R. Neves, M. Lùcio, J.L.C. Lima, S. Reis, Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions, Curr. Med. Chem. 19 (2012) 1663-1681.
17. M. Miksits, K. Wlcek, M. Svoboda, O. Kunert, E. Haslinger, T. Thalhammer, T. Szekeres, W. Jager, Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells, Planta Med. 75 (2009) 1227-1230.
18. J.D. Kenealey, L. Subramanian, P.R. Van Ginkel, S. Darjatmoko, M.J. Lindstrom, V. Somoza, S.K. Ghosh, Z. Song, R.P. Hsung, G.S. Kwon, K.W. Eliceiri, D.M. Albert, A.S. Polans, Resveratrol metabolites do not elicit early proapoptotic mechanisms in neuroblastoma cells, J. Agric. Food Chem. 59 (2011) 4979-4986.
19. B. Jannin, M. Menzel, J.-P. Berlot, D. Delmas, A. Lançon, N. Latruffe, Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake, Biochem. Pharmacol. 68 (2004) 1113-1118.
20. A. Lançon, D. Delmas, H. Osman, J.-P. Thffenot, B. Jannin, N. Latruffe, Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process, Biochem. Biophys. Res. Commun. 316 (2004) 1132-1137.
21. A. Amri, J.C. Chaumeil, S. Sfar, C. Charrueau, Administration of resveratrol: what formulation solutions to bioavailability limitations? J. Control. Release 158 (2012) 182-193.
22. J. Shao, X. Li, X. Lu, C. Jiang, Y. Hu, Q. Li, Y. You, Z. Fu, Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels, Colloids Surf. B Biointerfaces 72 (2009) 40-47.
23. N.K. Narayanan, D. Nargi, C. Randolph, B.A. Narayanan, Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice, Int. J. Cancer 125 (2009) 1-8.
24. A.C. Santos, F. Veiga, A.J. Ribeiro, New delivery systems to improve the bioavailability of resveratrol, Expert Opin. Drug Deliv. 8 (2011) 973-990.
25. G. Nicolosi, C. Spatafora, C. Tringali, Chemo-enzymatic preparation of resveratrol derivatives, J. Mol. Catal. B: Enzym 16 (2002) 223-229.
26. P. Torres, A. Poveda, J. Jimenez-Barbero, A. Ballesteros, F.J. Plou, Regioselective lipase-catalized synthesis of 3-O-acyl derivatives of resveratrol and study of their antioxidant properties, J. Agric. Food Chem. 58 (2010) 807-813.
27. B. Das, P. Thirupathi, R.A. Kumar, K. Laxminarayana, Part 148 in the series "Study on novel synthetic methodologies": selective acetylation of alcohols, phenols and amines and selective deprotection of aromatic acetates using silica-supported phosphomolybdic acid, Adv. Synth. Catal. 349 (2007) 2677-2683.
28. P.R. van Ginkel, D. Sareen, L. Subramanian, Q. Walker, S.R. Darjatmoko, M.J. Lindstrom, A. Kulkarni, D.M. Albert, A.S. Polans, Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria, Clin. Cancer Res. 13 (2007) 5162-5169.
29. D.W. Sullivan Jr., S.C. Gad, M. Julien, A review of the nonclinical safety of Transcutol®, a highly purified form of diethylene glycol monoethyl ether (DEGEE) used as a pharmaceutical excipient, Food Chem. Toxicol. 72 (2014) 40-50.
30. V. Cardile, R. Chillemi, L. Lombardo, S. Sciuto, C. Spatafora, C. Tringali, Antiproliferative activity of methylated analogues of E- and Z-resveratrol, Z Naturforsch C 62 (2007) 189-195.
31. M.C. Dixon, Quartz crystal microbalance with dissipation monitoring: enabling real-time characterization of biological materials and their interactions, J. Biomol. Tech. 19 (2008) 151-158.
32. P. Pospisil, L.K. Iyer, S.J. Adelstein, A.I. Kassis, A combined approach to data mining of textual and structured data to identify cancer-related targets, BMC Bioinforma. 7 (2006) 354.
33. A.N. Queiroz, B.A.Q. Gomes, W.M. Moraes Jr., R.S. Borges, A theoretical antioxidant pharmacophore for resveratrol, Eur. J. Med. Chem. 44 (2009) 1644-1649.
34. G.S. Jayatilake, B.J. Baker, J.B. McClintock, Isolation and identification of stilbene derivative from the antarctic sponge Kirkpartrickia variolosa, J. Nat. Prod. 58 (1995) 1958-1960.
35. G.D.K. Kumar, S. Baskara, A facile, catalytic and environmentally benign method for selective deprotection of tert-butyldimethylsilyl ether mediated by phosphomolybdic acid supported on silica gel, J. Org. Chem. 70 (2005) 4520-4523.
36. T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods 65 (1983) 55-63.
37. N.-J. Cho, C.W. Frank, B. Kasemo, F. Höök, Quartz crystal microbalance with dissipation monitoring of supported lipid bilayers on various substrates, Nat. Protoc. 5 (2010) 1096-1106.